China approves use of Pfizer's Covid drug Paxlovid
[BEIJING] China's medical products regulator said on Saturday (Feb 12) it has given conditional approval for Pfizer's Covid-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.
The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate Covid-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.
It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
Singapore-based Ryde accused of pump-and-dump fraud in class action lawsuit
Malaysia’s F1 return: A low-cost second chance, possible Singapore boost
Canada is upping oil flows to Asia, but South-east Asia’s refineries aren’t ready to handle them yet
